Sol-Gel Technologies Ltd.
TREATMENT OF OCULAR DISEASES WITH OPHTHALMIC TAPINAROF COMPOSITIONS

Last updated:

Abstract:

The present invention relates to the treatment of an ocular inflammatory disease or an ocular degeneration disease by ophthalmic administration of a composition comprising tapinarof and optionally at least one additional active agent. Specifically, the ocular inflammatory disease is blepharitis. This invention provides a treatment of blepharitis and Demodex mites.

Status:
Application
Type:

Utility

Filling date:

16 Nov 2021

Issue date:

10 Mar 2022